Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group (Q46782009)
Jump to navigation
Jump to search
scientific article published in February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group |
scientific article published in February 2008 |
Statements
1 reference
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group (English)
1 reference
1 reference
Ramesh K Ramanathan
1 reference
Merrill J Egorin
1 reference
Chris H M Takimoto
1 reference
Scot C Remick
1 reference
James H Doroshow
1 reference
Patricia A LoRusso
1 reference
Daniel L Mulkerin
1 reference
Jean L Grem
1 reference
Anne Hamilton
1 reference
Anthony J Murgo
1 reference
Douglas M Potter
1 reference
Michael J Hayes
1 reference
Bin Peng
1 reference
S Percy Ivy
1 reference
National Cancer Institute Organ Dysfunction Working Group
1 reference
1 February 2008
1 reference
26
1 reference
4
1 reference
563-569
1 reference
Identifiers
1 reference